Stereotactic Body Radiotherapy for Oligometastatic Disease in Melanoma Patients Receiving Immunotherapy: A Single-Center Retrospective Analysis.

Cancers (Basel) · 2026 · PMC13256329 · PMID 42279392

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although patients treated before or during immunotherapy appeared to have a longer PFS than those treated after immunotherapy, these differences did not reach statistical significance, likely due to the limited sample size.

also in 111,027 other papers

a numerical trendno p-value reported

A numerical trend toward longer PFS was observed among patients receiving SBRT during immunotherapy, although the differences were not statistically significant.

also in 1,012 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.